Categories: News

AI/ML’s CEO Appointed to Advisory Board of ST Innovations

TORONTO, March 2, 2021 /PRNewswire/ — AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that Randy Duguay, CEO of AI/ML Innovations Inc. was appointed to the University of Alberta’s ST Innovations Advisory Board in order to provide input and guidance regarding the commercialization of new technologies in the field of digital health innovations. 

“The addition of Randy Duguay to this prestigious advisory board is mutually beneficial” said Tim Daniels, Executive Chairman of AI/ML Innovations Inc. “Randy is able to share his wealth of expertise and experience in the field of digital health by mentoring and advising others, while simultaneously leveraging the human and technological resources of ST Innovations to the benefit of AI/ML Innovations.”

ST Innovations, the business arm of the University of Alberta’s SMART Network, is Alberta’s leading R&D services organization, connecting entrepreneurs with world-class researchers in support of the latest innovation and R&D. Combining a leading research network, specialized equipment and market insights, ST Innovations is a health technology development center focused on accelerating innovative health ideas at every stage by providing customized services which identify and remove barriers to the health innovation development process. (https://stinnovations.ca/)

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:
For detailed information please see AI/ML’s website at https://aiml-innovations.com/ or the Company’s filed documents at www.sedar.com.

For further information: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

Presentations:
Investor slidedeck:  https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf 
Corporate video:  https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be 
Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ

About AI/ML Innovations Inc.
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol “AIML”. AI/ML’s first acquisition was 70% ownership of Health Gauge.

About Health Gauge
Health Gauge’s patent-pending solution is a personal health monitoring & management system, which combines the latest wearable health monitors with sophisticated artificial intelligence software tools and proprietary cloud computing software, to help caregivers, patients, and healthcare professionals access and utilize relevant data, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

———————————————————————————————

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

 

View original content:http://www.prnewswire.com/news-releases/aimls-ceo-appointed-to-advisory-board-of-st-innovations-301238364.html

SOURCE AI/ML Innovations Inc.

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago